Axithra

Axithra develops a chip-based Raman spectroscopy platform for rapid therapeutic drug monitoring at the point of care. The technology measures the active, free fraction of drugs in patient blood to enable personalized dosing adjustments without sample pre-treatment. Its lead application targets the monitoring of beta-lactam antibiotics for patients in intensive care units, with future pipelines for oncology and antifungal treatments.